Announcement

Collapse
No announcement yet.

EBioMedicine . Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX)

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    No photos found.
Working...
X